Enzolytics (ENZC) Stock Statistics & Valuation Metrics

Enzolytics has a market cap or net worth of $2.36M. The enterprise value is $1.07M.

Enzolytics has 3,941,644,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzolytics’s return on equity (ROE) is 0.61 and return on invested capital (ROIC) is 126.43%.

The current PE Ratio of Enzolytics is -23.52. Enzolytics’s PEG ratio is >-0.01.

In the last 12 months, Enzolytics had revenue of 52.80K and earned -2.18M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 115.77M and capital expenditures 0.00, giving a free cash flow of 115.77M billion.

Enzolytics pays an annual dividend of $156.25, resulting in a dividend yield of ―

Enzolytics upcoming earnings date is ―, ―.

Enzolytics as a current ratio of 0.99, with Debt / Equity ratio of -51.33%

In the past 12 months, Enzolytics has paid 2.00 in taxes.

Enzolytics EV to EBITDA ratio is -24.58, with an EV/FCF ratio of -59.28.

Enzolytics has $200.00M in cash and marketable securities with $996.34K in debt, giving a net cash position of -$199.00M billion.

Gross margin is 0.00%, with operating margin of -4070.01%, and net profit margin of -4123.10%.

The average price target for Enzolytics is ―, which is 11.43% higher than the current price. The consensus rating is ―